Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction
Johann Bauersachs(Medizinische Hochschule Hannover), Uwe Kühl(German Centre for Cardiovascular Research), Verena Stangl(Deutsches Herzzentrum der Charité), Carolin Zwadlo(Medizinische Hochschule Hannover), Michael Böhm(Saarland University), Edith Podewski(Medizinische Hochschule Hannover), Valeska Abou Moulig(Medizinische Hochschule Hannover), Ingrid Kindermann(Baker Heart and Diabetes Institute), Roman Pfister(University of Cologne), Karen Sliwa(University of Cape Town), Ralf Westenfeld(Düsseldorf University Hospital), Tobias J. Pfeffer(Medizinische Hochschule Hannover), Annegret Franke(Leipzig University), Marziel Schwarzkopf(Leipzig University), Denise Hilfiker‐Kleiner(Medizinische Hochschule Hannover), Philipp Ehlermann(Heidelberg University), Dominik Berliner(Medizinische Hochschule Hannover), Jens Vogel‐Claussen(Medizinische Hochschule Hannover), Tobias König(Medizinische Hochschule Hannover), Johannes Schwab(MRC Laboratory of Molecular Biology), Guido Michels(Sankt-Antonius-Hospital Eschweiler)
Cited by 41
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k